BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22057290)

  • 1. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
    Ahmed N; Zeng M; Sinha I; Polin L; Wei WZ; Rathinam C; Flavell R; Massoumi R; Venuprasad K
    Nat Immunol; 2011 Nov; 12(12):1176-83. PubMed ID: 22057290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ndfip1 regulates itch ligase activity and airway inflammation via UbcH7.
    Kathania M; Zeng M; Yadav VN; Moghaddam SJ; Yang B; Venuprasad K
    J Immunol; 2015 Mar; 194(5):2160-7. PubMed ID: 25632008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
    Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
    J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
    Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
    J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.
    Nikolaou K; Tsagaratou A; Eftychi C; Kollias G; Mosialos G; Talianidis I
    Cancer Cell; 2012 Jun; 21(6):738-50. PubMed ID: 22698400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD.
    Zhang J; Ou J; Wan X
    Exp Cell Res; 2019 Oct; 383(1):111497. PubMed ID: 31301291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
    Ji YX; Huang Z; Yang X; Wang X; Zhao LP; Wang PX; Zhang XJ; Alves-Bezerra M; Cai L; Zhang P; Lu YX; Bai L; Gao MM; Zhao H; Tian S; Wang Y; Huang ZX; Zhu XY; Zhang Y; Gong J; She ZG; Li F; Cohen DE; Li H
    Nat Med; 2018 Feb; 24(2):213-223. PubMed ID: 29291351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It takes two to tango: a new couple in the family of ubiquitin-editing complexes.
    Wertz IE
    Nat Immunol; 2011 Nov; 12(12):1133-5. PubMed ID: 22089210
    [No Abstract]   [Full Text] [Related]  

  • 10. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
    Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
    J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
    Thuille N; Wachowicz K; Hermann-Kleiter N; Kaminski S; Fresser F; Lutz-Nicoladoni C; Leitges M; Thome M; Massoumi R; Baier G
    PLoS One; 2013; 8(1):e53709. PubMed ID: 23335970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase Itch inhibits p38α signaling and skin inflammation through the ubiquitylation of Tab1.
    Theivanthiran B; Kathania M; Zeng M; Anguiano E; Basrur V; Vandergriff T; Pascual V; Wei WZ; Massoumi R; Venuprasad K
    Sci Signal; 2015 Feb; 8(365):ra22. PubMed ID: 25714464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt.
    Lim JH; Jono H; Komatsu K; Woo CH; Lee J; Miyata M; Matsuno T; Xu X; Huang Y; Zhang W; Park SH; Kim YI; Choi YD; Shen H; Heo KS; Xu H; Bourne P; Koga T; Xu H; Yan C; Wang B; Chen LF; Feng XH; Li JD
    Nat Commun; 2012 Apr; 3():771. PubMed ID: 22491319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production.
    Vanlangenakker N; Vanden Berghe T; Bogaert P; Laukens B; Zobel K; Deshayes K; Vucic D; Fulda S; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2011 Apr; 18(4):656-65. PubMed ID: 21052097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.
    Zhang L; Wei N; Cui Y; Hong Z; Liu X; Wang Q; Li S; Liu H; Yu H; Cai Y; Wang Q; Zhu J; Meng W; Chen Z; Wang C
    PLoS Pathog; 2018 Nov; 14(11):e1007435. PubMed ID: 30388174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation.
    Liang L; Fan Y; Cheng J; Cheng D; Zhao Y; Cao B; Ma L; An L; Jia W; Su X; Yang J; Zhang H
    Cell Signal; 2013 Jan; 25(1):247-54. PubMed ID: 22981905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
    Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted role of the ubiquitin ligase Itch in immune regulation.
    Venuprasad K; Zeng M; Baughan SL; Massoumi R
    Immunol Cell Biol; 2015; 93(5):452-60. PubMed ID: 25582340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
    Ji YX; Zhang P; Zhang XJ; Zhao YC; Deng KQ; Jiang X; Wang PX; Huang Z; Li H
    Nat Commun; 2016 Jun; 7():11267. PubMed ID: 27249171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.